Research and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea.
World J Gastroenterol. 2022 Jul 21;28(27):3422-3434. doi: 10.3748/wjg.v28.i27.3422.
The biochemical phenomenon defined as poly adenosine diphosphate (ADP)-ribosylation (PARylation) is essential for the progression of pancreatic cancer. However, the excessive accumulation of poly ADP-ribose (PAR) induces apoptosis-inducing factor (AIF) release from mitochondria and energy deprivation resulting in the caspase-independent death of cancer cells.
To investigate whether sustained calcium supply could induce an anticancer effect on pancreatic cancer by PAR accumulation.
Two pancreatic cancer cell lines, AsPC-1 and CFPAC-1 were used for the study. Calcium influx and mitochondrial reactive oxygen species (ROS) were observed by fluorescence staining. Changes in enzyme levels, as well as PAR accumulation and energy metabolism, were measured using assay kits. AIF-dependent cell death was investigated followed by confirming anticancer effects by sustained calcium administration.
Mitochondrial ROS levels were elevated with increasing calcium influx into pancreatic cancer cells. Then, excess PAR accumulation, decreased PAR glycohydrolase and ADP-ribosyl hydrolase 3 levels, and energy deprivation were observed. and antitumor effects were confirmed to accompany elevated AIF levels.
This study visualized the potential anticancer effects of excessive PAR accumulation by sustained calcium supply on pancreatic cancer, however elucidating a clear mode of action remains a challenge, and it should be accompanied by further studies to assess its potential for clinical application.
多聚二磷酸腺苷核糖聚合(PAR 聚合)的生化现象对胰腺癌的进展至关重要。然而,多聚 ADP-核糖(PAR)的过度积累会诱导细胞色素 c 从线粒体中释放,并导致能量耗竭,从而引发细胞凋亡诱导因子(AIF)的释放,导致癌细胞发生 caspase 非依赖性死亡。
研究持续的钙供应是否通过 PAR 积累对胰腺癌产生抗癌作用。
使用两种胰腺癌细胞系 AsPC-1 和 CFPAC-1 进行研究。通过荧光染色观察钙内流和线粒体活性氧(ROS)的变化。使用试剂盒测量酶水平、PAR 积累和能量代谢的变化。通过持续钙给药确认 AIF 依赖性细胞死亡来研究细胞死亡。
随着钙流入胰腺癌细胞,线粒体 ROS 水平升高。随后观察到过量的 PAR 积累、PAR 糖基水解酶和 ADP-核糖基水解酶 3 水平降低以及能量耗竭。并证实伴随 AIF 水平升高,具有抗肿瘤作用。
本研究通过持续的钙供应可视化了过量 PAR 积累对胰腺癌的潜在抗癌作用,然而阐明其明确的作用模式仍然具有挑战性,并且应该进一步研究以评估其在临床应用中的潜力。